Scrub Typhus

LONDON , Oct. 9, 2023 /PRNewswire/ -- Colorectal Cancer often referred to as malignant colonic tumor, metastatic bowel cancer, metastatic colon carcinoma, or metastatic colorectal carcinoma, is a type of cancer that begins in the colon or rectum is a form of cancer occurring in the rectum or colon. It is an aggressive form of cancer that can rapidly spread to other parts of the digestive system. There has been an increased pervasiveness of this cancer equally affecting both men and women. Early detection in the form of colonoscopy screening plays a vital role in promoting fast prognosis. Drug development endeavours are also going on across various parts of the world with an aim to find a permanent cure for this ailment. The increased CRC disease burden has become a caused of concern for various nations. It is worth noting that colorectal cancer also known as metastatic rectal cancer usually begins as small, noncancerous growths called polyps on the inner lining of the colon or rectum. The growth of large polyp in colon takes the form of aggressive cancer if not diagnosed at an early stage. The colon is the large intestine, and the rectum is the last section of the colon, leading to the anus. Risk factors for colorectal cancer include age (the risk increases with age), a family history of the disease, certain genetic mutations, a diet high in red and processed meats, obesity, smoking, heavy alcohol consumption, and certain medical conditions such as inflammatory bowel disease (IBD). Price and Market Access The Market Competitors Listed Below are Revolutionizing Healthcare with Innovative Diagnostic Inventions: GI View Ltd Sun Pharmaceuticals Industries Ltd. Exact Sciences Corporation Becton, Dickinson, and Company DiagnoTech Corporation FUJIFILM Holdings America Corporation Cipla Ltd. QIAGEN MANCHESTER LTD Innovia Medical Gastro Diagnostics.Ltd KARL STORZ SE & Co. KG Thyrocare Technologies Epigenomics AG Cardinal Health Inc. Radiance Imaging System HUGER Medical Instrument Co., Ltd Apollo Diagnostics Roche Molecular Systems, Inc. Paramount Surgimed Limited UltraScan diagnostics Pro Scope Systems Fortis Healthcare Illumina, Inc. Integra LifeSciences Med Imaging Solutions MECAN MEDICAL EQUIPMENT CO LTD Epigenomics Ventana Medical Systems KAI Group Mindray Medical International Limited Others Learn More About the FDA NDA & BLA Approval (NME) Drugs for Colorectal Cancer @ DiseaseLandscape Insights has been offering healthcare consulting services to the players operating in this vertical. It is assisting them with clinical trial feasibility analysis, clinical trial management, price and market access, commercial strategy analysis, product portfolio extension, along with other pivotal activities. The industry participants are trying to strengthen their position in the CRC management landscape. Colorectal Cancer Disease Overview- Types, Causes, and Symptoms: Adenocarcinoma, Carcinoid Tumors, Gastrointestinal Stromal Tumors (GISTs), Lymphomas, and Sarcomas are the primary types of CRC. Although the exact causes behind its occurrence has not been known but genetic issues, age, unhealthy lifestyle, smoking, and alcohol intake, can be the triggering factors. The major symptoms are anemia, fatigue, weakness, blood in stool, changes in bowel habits, abdominal discomfort, and weight loss. Early detection can be life saving for patients. The diagnostic landscape of this disease is diverse wherein colonoscopy recommendations are given by doctors due to its accuracy. Colonoscopy screening age is typically 45 to 50 for average-risk individuals. Apart from that ct scan colon cancer and ct scan for bowel cancer, may also be suggested for the detection of colorectal malignant neoplasm. Effective treatment solutions are chemotherapy for colorectal cancer and radiation for rectal cancer. The latter uses high-energy radiation to target and destroy cancer cells in the rectum and can be administered alone or in combination with other treatments. Unlock the Benefits Today! Get Started Now and Elevate Your Experience @ Final Words: CRC is a highly prevalent forms of cancer affected a large part of the global population. It predominantly affects the digestive system specially the rectum, colon, and large intestine. Smoking, excessive alcohol intake, sedentary lifestyle, age, and family history, among others are known to be the factors leading to the onset of this ailment. DLI has been a support system for the players looking forward to transforming the CRC management. It has been assisting them with regulatory consulting, pharma consulting services, post launch strategies, product pipeline assessment, and treatment gaps identification. The sole aim of this health consultant and other players is to save the lives of the patients diagnosed with this devastating ailment. Browse Through More Oncology Diseases Research Reports. Related Reports: Insights and Trends in the Global Landscape of Lung Cancer Services The symptoms, transmission, and precautions of Monkeypox The Myths of Pneumonia: Symptoms, Causes, and Prevention Methods Navigating the Complex Autoimmune Disorder of Lupus Ringworm Comprehensive Guide: Symptoms, Causes, and Treatment Diverticulitis: A Complete Guide to the Symptoms, Causes, and Treatments When it comes to strategic Diabetes Disease consultancy, some of the areas we assist you understand include Regulatory Insights, Disease Landscape, and Market Access Expertise. Find treatments for HPV illness using specialized market entry strategies. FDA/EMA insights and clinical trial advice. Examine right away! Learn about specific approaches to Pancreatic Cancer Disease market access, pricing, and reimbursement. Learn about market research and clinical trials. Change your business immediately. Learn about KOLs, the FDA, epidemiology, price reimbursement, and more in this market report on Anemia Disease. Your trustworthy source for info on anemia. Examine right away! Chlamydia Disease symptoms, treatment, and market research. Keep up with epidemiology research, FDA and EMA updates, and market entry tactics. employing our tried-and-true strategy, penetrate the Ovarian Cancer Disease market. Learn to negotiate the regulatory process, discover the key opinion leaders for your product, and establish fair pricing. Learn about Gastric Cancer Market Strategies, KOL Insights, Regulatory Updates, and Market Intelligence. Make use of our knowledge to get through challenges. The success of the Breast Cancer market is built on FDA insights, pricing strategies, and a successful market launch. Investigate epidemiology and market intelligence to gain a competitive edge. Find out more about Prostate Cancer Consulting, FDA-EMA Drugs, Pricing, and Regulatory Insights. Obtain an epidemiology study and market access. Rely on DLI! FDA-EMA Approved Drugs, Disease Landscape, and Epidemiology Studies: Expert Consulting on Skin Cancer. Pricing Compensation and Market Access. Find out more about Tonsillitis symptoms, consulting services, drug costs, FDA-approved medications, disease landscape, regulatory insights, epidemiology, and price reimbursement. Investigate the epidemiology, prevention, and consulting services for Scrub Typhus. Discover the landscape of diseases, FDA-EMA approved medications, and more. Discover the market insights, competitive environment, regulatory updates, and epidemiology study for lymphoma. Market entry strategy: Unlock market intelligence. About Disease Landscape:  Disease Landscape, a pioneering company specializing in Disease Intelligence, Pricing, and Market Access. Utilizing the power of data analytics, Disease Landscape Insights is dedicated to healthcare sector with invaluable, finely crafted insights and recommendations regarding global pricing and market access strategies. As a specialized firm, we are committed to delivering unparalleled insights into pricing and market access, custom-tailored to the healthcare and pharmaceutical industries. Our data-driven solutions and cutting-edge technology position us as your trustworthy partner, offering swift, adaptable, and evidence-based alternatives to traditional market access and pricing research methods.  Our core competencies encompass Market Research Services, Consulting Services, Global Pricing and Market Access, Epidemiology Studies, as well as Product Portfolio and Pipeline Services. Our expertise lies in furnishing comprehensive data intelligence throughout every phase of drug and device research.  Contact Us:  Disease Landscape Insights LLP  6th Floor, Sr No.207, Office A H 6070 Phase 1  Solitaire Business Hub, Viman Nagar  Pune, Maharashtra, 411014  Email: [email protected] Email: [email protected] Sales: +44-2038074155  Asia Office: +917447409162 Blog:   Case Study:    Pharma consulting Services  Follow Us: LinkedIn | Twitter | Facebook Logo: SOURCE Disease Landscape Insights

LONDON, Oct. 2, 2023 /PRNewswire/ -- Breast cancer has emerged as a formidable adversary in the women's health realm. It is the third largest cause of female mortality, and its prevalence has increased by more than 20% since 2008. According to a recently conducted epidemiology study by the American Cancer Society, 1,958,310 new cancer cases and 609,820 cancer deaths are reckoned to occur in the United States alone by the end of 2023. Breast Cancer typically forms in breast tissue cells, mainly in ductal carcinoma (milk ducts) and lobular carcinoma (milk-producing lobules). Even though it can occur in both male and female populace, but the latter is the most vulnerable section. Breast cancer research activities are being conducted at a fast pace on a global level. Growing awareness about the severity of this disease and increased priority on women health are the top facts expediting R&D activities in this field. In order to reduce the rates of breast cancer incidence, the first and foremost step for medical researchers and healthcare experts is to gain complete disease insights. Without understanding the traits, underlying causes, and action mechanism of this cancer form, they cannot determine breast cancer risk factors and formulate effective treatment solutions. Being a complex disorder, it gets difficult for them to get a 360-degree disease overview. This is when they seek consulting services from DLI and leverage its deep dive healthcare expertise to enhance breast cancer research and treatment development activities. DLI empowers them with favourable market entry strategy while giving them a complete gist of the potential market barriers. The extensive market intelligence services offered by this health consultant enables industry participants to gain substantial market access. Price and Market Access Breast Cancer- A Health Menace: The concerning breast cancer statistics have pushed government bodies and healthcare entities to take crucial steps and improve the disease management landscape. The high breast cancer prevalence has increased the demand for early diagnosis and medical intervention. This malignancy, if detected at its initial stage can be cured. But in case of late diagnosis, the cancer spreads to other organs, resulting in severe health complications and fatality. Underlying causes of breast cancer cannot be accurately determined. The triggering factors may vary from person to person. Although, family history, genetic defects, hormonal imbalances, unhealthy lifestyle, radiation exposure, and age may contribute in the onset of this devastating disease. It is crucial to identify the initial symptoms that point toward an increased chance of breast cancer occurrence. The primary symptoms include notable lump in the breast, nipple changes, skin chances, weight loss, breast pain, and changes in breast shape or size. Breast risk assessment tests or screenings are crucial to diagnose this life threating condition. Early diagnosis plays a significant role in increasing the breast cancer recovery rate worldwide. Learn More About the FDA NDA & BLA Approval (NME) Drugs for Breast Cancer @ Diagnostic and Treatment Landscape: The diagnostic landscape for this disease is vast. It comprises of a combination of different techniques namely- Breast examination- It involves the physical examination of the breasts, checking for any lumps, changes in shape or size, or abnormalities in the nipples or surrounding skin. Imaging tests- Mammogram, breast MRI, and breast ultrasound are some of imaging tests recommended to detect cancerous lumps inside the breast. Biopsy- Surgical biopsy, fine needle aspiration, and core needle biopsy can be conducted to confirm the presence of cancer. Genetic testing- Genetic testing can identify mutations in genes like BRCA1 and BRCA2 that increase the risk of breast cancer. Apart from that, certain laboratory tests, staging, and medical history assessment are also some of the preferred can diagnostic techniques. Post detection, patients should get immediate medical attention. If ideal treatment therapeutics are prescribed in the right time, the risk of complications and mortality gets reduced to a large extent. With rigorous R&D, effective treatment solutions have been developed. Some of the most commonly suggested treatments are lumpectomy, mastectomy, chemotherapy, radiation therapy, immunotherapy, targeted therapy, hormone therapy, and breast reconstruction, among others. Discover More About Pricing and Reimbursement, Epidemiology Study, and Healthcare @ Role of DLI in Clinical Trial Management: For any drugs or treatment therapy to get the approval of regulatory bodies like FDA, the smooth conduction of clinical trials plays a crucial role. Without successful clearance of clinical trial assessment phases, no treatment entities can be launched in the market for commercial use. It is evident that these trials can be time consuming and rigorous for the participants. DLI helps in easing the entire process by helping them with data analysis and interpretation, clinical trial feasibility analysis of their potential product, patient population identification, regulatory barriers assessment, while providing that with extensive market intelligence research documents. Prior to the clinical trial phase, DLI has also assisted players in their drug development endeavours by facilitating treatment gaps identification and other similar activities. Through its pharma consulting services, it has helped the concerned firms in terms of commercial strategy analysis, product portfolio analysis, price and market access-based decisions while offering them with exclusive post launch services. It can be said that DLI has been a constant support to the industry participants involved with the development of advanced breast cancer treatment solutions. Unlock the Benefits Today! Get Started Now and Elevate Your Experience @ Final Words: Breast cancer is one of the most dreadful malignancies, affecting a significant portion of the global female population. The proper management of this ailment is necessary to save the lives of many. The high breast cancer disease burden has emerged as a cause of concern for many nations. Medical scientists, government authorities, and other healthcare professionals worldwide have joined hands to make extensive efforts and eradicate this menace called breast cancer. They are investing in R&D activities to develop rapid and effective diagnostic and treatment solutions. Many of them have collaborated with DLI to expedite their activities by leveraging its deep dive healthcare expertise. By offering expertise in data analysis, patient population identification, competitive landscape assessment, regulatory compliance, and more, DLI contributes significantly to advancing drug development, enhancing clinical trial management, along with product portfolio extension in the fight against breast cancer. Search more about Oncology Diseases Related Reports: Insights and Trends in the Global Landscape of Lung Cancer Services The symptoms, transmission, and precautions of Monkeypox The Myths of Pneumonia: Symptoms, Causes, and Prevention Methods Navigating the Complex Autoimmune Disorder of Lupus Ringworm Comprehensive Guide: Symptoms, Causes, and Treatment Diverticulitis: A Complete Guide to the Symptoms, Causes, and Treatments When it comes to strategic Diabetes Disease consultancy, some of the areas we assist you understand include Regulatory Insights, Disease Landscape, and Market Access Expertise. Find treatments for HPV illness using specialized market entry strategies. FDA/EMA insights and clinical trial advice. Examine right away! Learn about specific approaches to Pancreatic Cancer Disease market access, pricing, and reimbursement. Learn about market research and clinical trials. Change your business immediately. Learn about KOLs, the FDA, epidemiology, price reimbursement, and more in this market report on Anemia Disease. Your trustworthy source for info on anemia. Examine right away! Chlamydia Disease symptoms, treatment, and market research. Keep up with epidemiology research, FDA and EMA updates, and market entry tactics. Employing our tried-and-true strategy, penetrate the Ovarian Cancer Disease market. Learn to negotiate the regulatory process, discover the key opinion leaders for your product, and establish fair pricing. Learn about Gastric Cancer Market Strategies, KOL Insights, Regulatory Updates, and Market Intelligence. Make use of our knowledge to get through challenges. Find out more about Prostate Cancer Consulting, FDA-EMA Drugs, Pricing, and Regulatory Insights. Obtain an epidemiology study and market access. Rely on DLI! FDA-EMA Approved Drugs, Disease Landscape, and Epidemiology Studies: Expert Consulting on Skin Cancer. Pricing Compensation and Market Access. Find out more about Tonsillitis symptoms, consulting services, drug costs, FDA-approved medications, disease landscape, regulatory insights, epidemiology, and price reimbursement. Investigate the epidemiology, prevention, and consulting services for Scrub Typhus. Discover the landscape of diseases, FDA-EMA approved medications, and more About Disease Landscape:  Disease Landscape, a pioneering company specializing in Disease Intelligence, Pricing, and Market Access. Utilizing the power of data analytics, Disease Landscape Insights is dedicated to healthcare sector with invaluable, finely crafted insights and recommendations regarding global pricing and market access strategies. As a specialized firm, we are committed to delivering unparalleled insights into pricing and market access, custom-tailored to the healthcare and pharmaceutical industries. Our data-driven solutions and cutting-edge technology position us as your trustworthy partner, offering swift, adaptable, and evidence-based alternatives to traditional market access and pricing research methods.  Our core competencies encompass Market Research Services, Consulting Services, Global Pricing and Market Access, Epidemiology Studies, as well as Product Portfolio and Pipeline Services. Our expertise lies in furnishing comprehensive data intelligence throughout every phase of drug and device research.  Contact Us:  Disease Landscape Insights LLP  6th Floor, Sr No.207, Office A H 6070 Phase 1  Solitaire Business Hub, Viman Nagar  Pune, Maharashtra, 411014  Email: [email protected]    Email: [email protected] Sales: +44-2038074155  Asia Office: +917447409162 Blog:   Case Study:    Pharma consulting Services  Follow Us: LinkedIn | Twitter | Facebook  Logo: SOURCE Disease Landscape Insights

A bacterium that causes a disease called scrub typhus -- a disease not previously reported in the United States -- has been detected in North Carolina, according to a new study. A bacterium that causes a disease called scrub typhus -- a disease not previously reported in the United States -- has been detected in North Carolina, according to a new study by researchers at North Carolina State University and UNC-Greensboro. The researchers stress that scrub typhus, which can cause fever, headache and body aches -- and can be fatal if left untreated by antibiotics -- has not yet been detected in animals or people in the state. The NC State researchers detected the bacterium -- the genus is Orientia in the family Rickettsiaceae -- at a high frequency while testing free living, larval (ready to bite) trombiculid mites, commonly called chiggers, in several different recreational parks in North Carolina. "We wanted to see if chiggers in the United States carried Orientia," said Loganathan Ponnusamy, an NC State principal research scholar in entomology and co-corresponding author of a paper that describes the research. "We haven't in the past had the diagnostic tools to test for this specific bacterium at the genus level." "We set a black tile on the ground in 10 different North Carolina state parks and picked up chiggers as they crossed the tile. Microbiome studies allowed us to characterize all the bacteria in the chiggers. One park showed a 90% positivity rate for the bacterium (nine out of 10 chiggers captured); another showed an 80% positivity rate (eight of 10 chiggers captured). Other parks showed positivity rates of just 10%." Trombiculid mites are only parasitic in their larval stage. They search for vertebrate hosts -- including humans -- to bite, Ponnusamy says. "Chiggers can spread bacteria to people or rodents when they bite but can also pass bacteria to future generations of mites through their eggs," he added. The researchers say that scrub typhus presents symptoms similar to those of Rocky Mountain spotted fever, a disease generally ascribed to tick bites. Scrub typhus is found more commonly in Asia and the Pacific, but in recent years has been detected in Africa and the Middle East. It is uncertain whether spread is caused by people or goods carrying chiggers from one place to another. "We don't know if this is a recent introduction into the state or if the bacterium has been here for years," said R. Michael Roe, William Neal Reynolds Distinguished Professor of Entomology at NC State and co-author of the paper. "We also don't know if the infected chiggers found in North Carolina actually will cause disease; this has to be determined in future work." "We also don't have information about whether the chigger infection rate is decreasing or increasing," said Kaiying Chen, a postdoctoral research scholar at NC State and lead author of the paper. The NC State and UNC-Greensboro researchers are resampling chiggers in the recreational park sites to see if the reported findings remain consistent. The paper appears in the journal Emerging Infectious Diseases. Other co-authors include Nicholas V. Travanty and Charles S. Apperson from North Carolina State University; Reuben Garshong and Gideon Wasserberg from the University of North Carolina Greensboro; and Dac Crossley from the Georgia Museum of Natural History. Funding was provided by a grant from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (grant no. 1R03AI166406-01); a grant from the Southeast Center for Agricultural Health and Injury Prevention, and from the Department of the Army, U.S. Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, Ft Detrick MD. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the position or the policy of the Government and no official endorsement should be inferred.